Shahin Lauren, Patel Komal M, Heydari Milad K, Kesselman Marc M
Rheumatology, Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Davie, USA.
Cureus. 2021 May 5;13(5):e14855. doi: 10.7759/cureus.14855.
As the prevalence of hyperuricemia (elevated uric acid levels in the blood) increases, the relationship between serum uric acid levels and cardiovascular risk has garnered increased interest. Several studies have highlighted that elevated uric acid levels are likely tied to increased cardiovascular disease risk. Specifically, the presence of hyperuricemia is well-established to contribute to the onset of gout (an inflammatory condition characterized by painful/swollen joints). Several studies have shown that the risk of developing gout is strongly associated with the degree of hyperuricemia. In this review, we will provide insight into the association between gout and cardiovascular disease risk. It is also important to gain insight into the pathophysiology of gout to understand the contributions to cardiovascular disease risk as well as improve diagnosis and target treatment more effectively. An interdisciplinary approach for gout management and areas for further investigation will be discussed in this review.
随着高尿酸血症(血液中尿酸水平升高)患病率的增加,血清尿酸水平与心血管风险之间的关系已引起越来越多的关注。多项研究强调,尿酸水平升高可能与心血管疾病风险增加有关。具体而言,高尿酸血症的存在与痛风(一种以关节疼痛/肿胀为特征的炎症性疾病)的发作密切相关。多项研究表明,患痛风的风险与高尿酸血症的程度密切相关。在本综述中,我们将深入探讨痛风与心血管疾病风险之间的关联。深入了解痛风的病理生理学对于理解其对心血管疾病风险的影响以及更有效地改善诊断和靶向治疗也很重要。本综述将讨论痛风管理的跨学科方法以及进一步研究的领域。